secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ginkgo Bioworks Holdings, Inc. (DNA)
CIK:        0001830214
Form:       8-K
Filed at:   2026-07-30T20:06:06+00:00
Accession:  0001628280-26-051041
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ginkgo Bioworks schedules Q2 2026 earnings call for August 5, 2026
------------------------------------------------------------------

- Presentation and Q&A session on Wednesday, August 5, 2026 at 4:30 p.m. ET.
- Webcast link and replay available on Ginkgo's investor relations website.
- Shareholders can submit questions via X (#GinkgoResults) or email to investors@ginkgobioworks.com.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1830214/000162828026051041/0001628280-26-051041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1830214/000162828026051041/dna-20260730.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-051041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer